Ophthalmic Drug Delivery Systems / Edition 2

Ophthalmic Drug Delivery Systems / Edition 2

by Ashim K. Mitra
ISBN-10:
0367446766
ISBN-13:
9780367446765
Pub. Date:
12/02/2019
Publisher:
CRC Press
ISBN-10:
0367446766
ISBN-13:
9780367446765
Pub. Date:
12/02/2019
Publisher:
CRC Press
Ophthalmic Drug Delivery Systems / Edition 2

Ophthalmic Drug Delivery Systems / Edition 2

by Ashim K. Mitra

Paperback

$82.99
Current price is , Original price is $82.99. You
$82.99 
  • SHIP THIS ITEM
    Qualifies for Free Shipping
  • PICK UP IN STORE
    Check Availability at Nearby Stores

Overview

The second edition of this text assembles significant ophthalmic advances and encompasses breakthroughs in gene therapy, ocular microdialysis, vitreous drug disposition modelling, and receptor/transporter targeted drug delivery.


Product Details

ISBN-13: 9780367446765
Publisher: CRC Press
Publication date: 12/02/2019
Edition description: 2nd ed.
Pages: 847
Product dimensions: 6.00(w) x 9.00(h) x (d)

Table of Contents

I: Fundamental Considerations 1. Overview of Ocular Drug Delivery 2. Membrane Transport Processes in the Eye 3. General Considerations in Ocular Drug Delivery II: Transport Models in Ocular Drug Delivery 4. Ocular Drug Transfer following Systemic Drug Administration 5. Ocular Pharmacokinetics and Pharmacodynamics 6. Mathematical Modeling of Drug Distribution in the Vitreous Humor 7. Anterior Segment Microdialysis 8. Posterior Segment Microdialysis III: Drug Delivery Systems 9. Ocular Penetration Enhancers 10. Corneal Collagen Shields for Ocular Drug Delivery 11. The Noncorneal Route in Ocular Drug Delivery 12. Ocular Iontophoresis 13. Mucoadhesive Polymers in Ophthalmic Drug Delivery 14. Microparticles and Nanoparticles in Ocular Drug Delivery 15. Dendrimers: An Innovative and Enhanced Ocular Drug Delivery System 16. Ocular Delivery and Therapeutics of Proteins and Peptides 17. Retinal Disease Models for Development of Drug and Gene Therapies 18. New Experimental Therapeutic Approaches for Degenerative Diseases of the Retina 19. Gene, Oligonucleotide, and Ribozyme Therapy in the Eye IV: Regulatory Aspects 20. Regulatory Considerations 21. Patent Considerations
From the B&N Reads Blog

Customer Reviews